Astellas-backed immuno-oncology drug developer Crescendo Biologics has secured $70m in a Takeda Ventures-backed round.

The UCL spinout has secured an additional licence to a protein that aims to reduce side effects associated with its Car T immuno-oncological approach.

Swisscom, Avaloq, Swiss Post and Sicpa have all backed a round of undisclosed size for the cryptocurrency and blockchain technology provider.

GraphicsFuzz will launch a security testing tool for graphics drivers to catch potential flaws using a metamorphic approach.

Existing backers Legal and General Capital and Statoil Energy Ventures have returned for an $11.2m round that took Oxford PV's total financing to $77m.

The government-owned Scottish Investment Bank has returned to pour more funding into Strathclyde mycoprotein spinout 3F Bio.

Erkki Aaltonen has left StartAD to oversee YaraGerminate, a corporate venturing fund formed by Yara International.